Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
McKinsey
Farmers Insurance
Moodys
Dow
Argus Health
Medtronic
Mallinckrodt
Covington

Generated: November 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200179

« Back to Dashboard

NDA 200179 describes STAXYN, which is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge. Additional details are available on the STAXYN profile page.

The generic ingredient in STAXYN is vardenafil hydrochloride. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the vardenafil hydrochloride profile page.
Summary for 200179
Tradename:STAXYN
Applicant:Bayer Hlthcare
Ingredient:vardenafil hydrochloride
Patents:3
Formulation / Manufacturing:see details
Pharmacology for NDA: 200179
Suppliers and Packaging for NDA: 200179
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
STAXYN vardenafil hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 200179 NDA GlaxoSmithKline LLC 0173-0822 0173-0822-04 1 BLISTER PACK in 1 BOX (0173-0822-04) > 4 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
STAXYN vardenafil hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 200179 NDA GlaxoSmithKline LLC 0173-0822 0173-0822-14 10 BLISTER PACK in 1 BOX (0173-0822-14) > 4 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, ORALLY DISINTEGRATING;ORALStrength10MG
Approval Date:Jun 17, 2010TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Oct 31, 2018Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF ERECTILE DYSFUNCTION
Patent:➤ Try a Free TrialPatent Expiration:Oct 31, 2018Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF ERECTILE DYSFUNCTION
Patent:➤ Try a Free TrialPatent Expiration:Dec 23, 2028Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 200179

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare STAXYN vardenafil hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 200179-001 Jun 17, 2010 ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Hlthcare STAXYN vardenafil hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 200179-001 Jun 17, 2010 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Fish and Richardson
Chinese Patent Office
AstraZeneca
Colorcon
Citi
Cipla
Dow
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.